| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/24/2008 | WO2008156642A1 Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growth |
| 12/24/2008 | WO2008156622A1 Humanized antibodies to amyloid beta |
| 12/24/2008 | WO2008156621A1 Monoclonal anti beta amyloid antibody |
| 12/24/2008 | WO2008156415A1 Rapid fungal detection assay and product |
| 12/24/2008 | WO2008156409A1 Separation method using polymer multi phase systems |
| 12/24/2008 | WO2008156269A1 Recombinant antibodies capable of binding to a cancer specific marker and uses thereof |
| 12/24/2008 | WO2008156124A1 Method for separation of immunoglobulin monomer |
| 12/24/2008 | WO2008156083A1 Method for measuring bonding activity of antibody which mimics antibody-dependent cell-mediated cytotoxic activity |
| 12/24/2008 | WO2008156069A1 Screening method for antibody and antibody obtained by the method |
| 12/24/2008 | WO2008155918A1 REGULATION OF HIF-1 BY MT1-MMP, iFIH AND FIH-1 |
| 12/24/2008 | WO2008155891A1 Novel marker for arteriosclerotic disease |
| 12/24/2008 | WO2008155387A2 Anti-igf antibodies that bind to igf-1 and igf-2 but not to insulin |
| 12/24/2008 | WO2008155365A1 Methods and compositions for treating allergic diseases |
| 12/24/2008 | WO2008154927A1 Novel methods for treating egfr-associated tumors |
| 12/24/2008 | WO2008154814A1 OPTIMIZED TACI-Fc FUSION PROTEINS |
| 12/24/2008 | WO2008154813A1 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 12/24/2008 | WO2008137500A3 Immunosuppression with antibody against itm2a |
| 12/24/2008 | WO2008134759A3 Treatment of myeloproliferative disorders with adaptor protein lnk |
| 12/24/2008 | WO2008134659A3 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |
| 12/24/2008 | WO2008130704A3 PDGFRβ-SPECIFIC INHIBITORS |
| 12/24/2008 | WO2008130433A3 Methods for providing prophylactic surface treatment for fluid processing systems and components thereof |
| 12/24/2008 | WO2008112840A3 Novel composition and methods for the treatment of immune related diseases |
| 12/24/2008 | WO2008109757A3 Methods and compositions involving polymeric immunoglobulin fusion proteins |
| 12/24/2008 | WO2008101234A8 Anti ganglioside gd3 antibodies and uses thereof |
| 12/24/2008 | WO2008101184A3 Arl-1 specific antibodies |
| 12/24/2008 | WO2008097866A3 Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells |
| 12/24/2008 | WO2008084410A3 Human cytomegalovirus neutralising antibodies and use thereof |
| 12/24/2008 | WO2008076487A3 Antibodies and methods for making and using them |
| 12/24/2008 | WO2008060617A3 Therapeutic uses of tim-3 modulators |
| 12/24/2008 | WO2008030611A3 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 12/24/2008 | WO2008009002A3 Reagents for the detection of protein phosphorylation in signaling pathways |
| 12/24/2008 | WO2008008998A3 Reagents for the detection of protein phosphorylation in signaling pathways |
| 12/24/2008 | WO2008008709A3 Method of selective protein enrichment and associated applications |
| 12/24/2008 | WO2008008553A3 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof |
| 12/24/2008 | WO2006113050A3 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
| 12/24/2008 | WO2006072152A3 Suppressor of disease-associated autoreactive b iymphocytes |
| 12/24/2008 | EP2006685A1 Immune agglutination reaction reagent kit and method of assaying antigen |
| 12/24/2008 | EP2006683A1 Human megalin determination method |
| 12/24/2008 | EP2006382A1 Dopamine-producing neuron progenitor cell marker 187a5 |
| 12/24/2008 | EP2006381A1 Method for control of blood kinetics of antibody |
| 12/24/2008 | EP2006380A1 Agonistic antibody directed against human thrombopoietin receptor |
| 12/24/2008 | EP2006379A1 High functional bispecific antibody |
| 12/24/2008 | EP2006375A2 Panel cell used for granulocyte antibody detection |
| 12/24/2008 | EP2006305A2 Modified antibody with enhanced bioactivity |
| 12/24/2008 | EP2006304A1 Anti-HPA-5b monoclonal antibody |
| 12/24/2008 | EP2006303A1 Recombinant antibodies specific for Beta-Amyloid ends, DNA encoding and methods of use thereof |
| 12/24/2008 | EP2006300A2 Characterization of a calcium channel family |
| 12/24/2008 | EP2006294A1 Tumour-associated peptides that bind to MHC molecules |
| 12/24/2008 | EP2005996A2 Immunotherapeutic combination for the treatment of tumors |
| 12/24/2008 | EP2005966A1 Survivin-derived peptides and use thereof |
| 12/24/2008 | EP2005186A2 Ercc1 expression in predicting response for cancer chemotherapy |
| 12/24/2008 | EP2004850A2 Interfering in activation of an immune cell by influencing interaction of lair and collagen. |
| 12/24/2008 | EP2004697A2 Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof |
| 12/24/2008 | EP2004696A1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
| 12/24/2008 | EP2004695A2 Optimized anti-ep-cam antibodies |
| 12/24/2008 | EP2004694A2 Methods for preventing and treating amyloidogenic diseases |
| 12/24/2008 | EP2004693A2 Compositions and methods of use for antibodies of c-met |
| 12/24/2008 | EP2004692A1 Treatment of multiple sclerosis and/or rheumatoid arthritis |
| 12/24/2008 | EP2004691A1 Antibody specific for human il-4 for the treament of cancer |
| 12/24/2008 | EP2004690A2 Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling |
| 12/24/2008 | EP2004689A2 Antibody purification |
| 12/24/2008 | EP2004688A1 Improved protofibril selective antibodies and the use thereof |
| 12/24/2008 | EP2004687A1 Methods for damaging cells using effector functions of anti-cdh3 antibodies |
| 12/24/2008 | EP2004686A1 Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections |
| 12/24/2008 | EP2004685A2 Hepatitis c virus neutralizing antibodies |
| 12/24/2008 | EP2004684A2 Hepatitis c virus neutralizing antibodies |
| 12/24/2008 | EP2004232A2 Method and composition for treatment of renal disease with antibodies and their equivalents |
| 12/24/2008 | EP2004229A2 Concentrate of immunoglobulins and f(ab)'2 and/or fab fragments specific of an arbovirus as medicine |
| 12/24/2008 | EP2004228A1 Methods for damaging cells using effector functions of anti-epha4 antibodies |
| 12/24/2008 | EP2004221A2 Anti-tumor cell antigen antibody therapeutics |
| 12/24/2008 | EP2003960A2 Transgenic animals expressing chimeric antibodies for use in preparing human antibodies |
| 12/24/2008 | EP1218511B1 Antimicrobial compositions |
| 12/24/2008 | EP1181555B1 Cancer treatment with endothelin receptor antagonists |
| 12/24/2008 | EP1003773B1 Ctl epitopes of epstein-barr virus |
| 12/24/2008 | EP0909277B2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 12/24/2008 | DE102007028687A1 Composition for treating an autoimmune disease in an individual comprises an autologous antigen that induces an autoimmune reaction |
| 12/24/2008 | DE102007028659A1 Diagnosesubstanz und Verfahren zur Diagnose von Prostataerkrankungen Diagnostic substance and method for the diagnosis of prostate disease |
| 12/24/2008 | CN101331228A Transgenic silkworm capable of producing antibody and method for production thereof |
| 12/24/2008 | CN101331223A Cell display of antibody libraries |
| 12/24/2008 | CN101331151A Means and methods for the treatment of tumorous diseases |
| 12/24/2008 | CN101331150A Human monoclonal antibody human CD134 (OX40) and methods of making and using same |
| 12/24/2008 | CN101330923A 治疗性疫苗 Therapeutic vaccine |
| 12/24/2008 | CN101328484A Delta-endotoxin genes and methods for their use |
| 12/24/2008 | CN101328473A Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom |
| 12/24/2008 | CN101328219A Nano liposome anti-HPV, gynecological inflammation pathogen specific compound IgY and combined preparation thereof |
| 12/24/2008 | CN101328211A Two leptospira outer membrane proteins of vaccine candidates |
| 12/24/2008 | CN100444838C Use of inhibitors for treatment of disorders related to RTK hyperfunction |
| 12/24/2008 | CA2855098A1 Antibodies to human programmed death receptor pd-1 |
| 12/24/2008 | CA2691892A1 Anti-il-20 antibody and its use in treating il-20 associated inflammatory diseases |
| 12/24/2008 | CA2691434A1 Covalent diabodies and uses thereof |
| 12/24/2008 | CA2691357A1 Antibodies to human programmed death receptor pd-1 |
| 12/24/2008 | CA2691322A1 Anti-cd20 therapeutic compositions and methods |
| 12/24/2008 | CA2691157A1 Methods and compositions for treating allergic diseases |
| 12/24/2008 | CA2690435A1 Humanized antibodies to amyloid beta |
| 12/24/2008 | CA2690434A1 Monoclonal anti beta amyloid antibody |
| 12/24/2008 | CA2690382A1 Antibody formulations |
| 12/24/2008 | CA2690271A1 Chlamydia antigens |
| 12/24/2008 | CA2689521A1 Anti-igf antibodies |
| 12/24/2008 | CA2687720A1 Il-17 heteromeric receptor complex |
| 12/23/2008 | US7468427 Antibodies to PRO1275 polypeptide |